Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Vitexin-2-o-rhamnoside
1. Vitexin-2-o-rhamnoside
2. 64820-99-1
3. 2-o-rhamnosylvitexin
4. Vitexin 2''-rhamnoside
5. Vitexin-2''-rhamnoside
6. 2''-o-rhamnosylvitexin
7. Vitexin-2''-o-rhamnoside
8. Rhamnosylvitexin
9. 2''-rhamnosylvitexin
10. Ud7y63i5x5
11. Chebi:32298
12. Vitexin 2''-o-alpha-l-rhamnoside
13. Apigenin-8-c-glucoside-2'-rhamnoside
14. Vitexin-2"-o-rhamnoside
15. (1s)-1,5-anhydro-2-o-(6-deoxy-alpha-l-mannopyranosyl)-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-8-yl]-d-glucitol
16. (1s)-1,5-anhydro-2-o-(alpha-l-rhamnopyranosyl)-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-8-yl]-d-glucitol
17. Unii-ud7y63i5x5
18. Vitexin-2 Inverted Exclamation Marka-o-rhamnoside
19. Vitexin 2"-o-rhamnoside
20. Megxp0_001018
21. Schembl1954688
22. Chembl1685070
23. Acon1_001257
24. Dtxsid20215119
25. Hy-n0534
26. Zinc4654801
27. 2''-o-rhamnopyranosylvitexin
28. Mfcd29913069
29. S5460
30. Akos015897136
31. Ccg-270120
32. Ncgc00169526-01
33. 8-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
34. 8-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
35. As-57695
36. Vitexin 2-o-rhamnoside, Analytical Standard
37. Cs-0009067
38. Vitexin-2invertedexclamationmarka-o-rhamnoside
39. Brd-k00786504-001-01-8
40. Q27114859
41. Vitexin 2-o-rhamnoside, Primary Pharmaceutical Reference Standard
42. Vitexin-2''-o-rhamnoside (constituent Of Hawthorn Leaf With Flower) [dsc]
43. 8-((2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2-yl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-chromen-4-one
| Molecular Weight | 578.5 g/mol |
|---|---|
| Molecular Formula | C27H30O14 |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 5 |
| Exact Mass | 578.16355563 g/mol |
| Monoisotopic Mass | 578.16355563 g/mol |
| Topological Polar Surface Area | 236 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 954 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A 2-O-Rhamnosylvitexin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-O-Rhamnosylvitexin, including repackagers and relabelers. The FDA regulates 2-O-Rhamnosylvitexin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-O-Rhamnosylvitexin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 2-O-Rhamnosylvitexin supplier is an individual or a company that provides 2-O-Rhamnosylvitexin active pharmaceutical ingredient (API) or 2-O-Rhamnosylvitexin finished formulations upon request. The 2-O-Rhamnosylvitexin suppliers may include 2-O-Rhamnosylvitexin API manufacturers, exporters, distributors and traders.
2-O-Rhamnosylvitexin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2-O-Rhamnosylvitexin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2-O-Rhamnosylvitexin GMP manufacturer or 2-O-Rhamnosylvitexin GMP API supplier for your needs.
A 2-O-Rhamnosylvitexin CoA (Certificate of Analysis) is a formal document that attests to 2-O-Rhamnosylvitexin's compliance with 2-O-Rhamnosylvitexin specifications and serves as a tool for batch-level quality control.
2-O-Rhamnosylvitexin CoA mostly includes findings from lab analyses of a specific batch. For each 2-O-Rhamnosylvitexin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2-O-Rhamnosylvitexin may be tested according to a variety of international standards, such as European Pharmacopoeia (2-O-Rhamnosylvitexin EP), 2-O-Rhamnosylvitexin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2-O-Rhamnosylvitexin USP).
LOOKING FOR A SUPPLIER?
